Poster Video: Induction of an effective immune response is an essential element of cancer immunotherapy
September 2, 2025
One way to identify the patients likely to respond to immunotherapy is by identifying the distribution of inflammatory cells relative to tumor cells. However, in spite of the compelling association of immune phenotypes with clinical outcome, there are not yet standard definitions or scoring methods.
See how our scientists developed a method for pathologists to identify desert, excluded and inflamed immune phenotypes in our new video!
Poster Video: Induction of an effective immune response is an essential element of cancer immunotherapy
September 2, 2025
One way to identify the patients likely to respond to immunotherapy is by identifying the distribution of inflammatory cells relative to tumor cells. However, in spite of the compelling association of immune phenotypes with clinical outcome, there are not yet standard definitions or scoring methods.
See how our scientists developed a method for pathologists to identify desert, excluded and inflamed immune phenotypes in our new video!
In 2019, CellCarta proudly opened a state-of-the-art CRO laboratory in Jining, China, expanding our global footprint to support the evolving needs of clinical research.
This facility plays a key role in our global CRO network, serving biopharma clients with clinical trials running in China.
It is equipped with advanced technologies and offers a comprehensive suite of services designed to deliver high-quality data and reliable results for a variety of scientific and clinical applications.
Watch the video to discover our China laboratory:
Exclusive Services by CellCarta: A Quick Overview
Flow Cytometry Service
Our Jining laboratory is equipped with the following flow cytometry platforms: BD FACSLyric™ and BD LSRFortessa™.
As a global CRO with extensive flow cytometry expertise, we support discovery and preclinical research in addition to clinical trials across therapeutic areas.
Immunohistochemistry (IHC) and In Situ Hybridisation (ISH)
We offer robust IHC and ISH services, essential for detailed tissue analysis and molecular diagnostics.
Our techniques ensure accurate detection and localization of biomarkers, providing critical insights for various research applications, and the high quality data required for regulatory submissions.
Genomic Services
Our genomic services include real-time PCR and NanoString technologies. Real-time PCR allows for precise quantification of nucleic acids, while NanoString offers high-throughput gene expression analysis.
Proteomic and Immunoassay Services
Our Jining laboratory utilizes the Olink® and Meso Scale Discovery (MSD) platforms for high throughput proteomic analyses. These technologies facilitate comprehensive cytokine profiling and biomarker discovery, supporting translational research and global clinical studies.
ELISpot (ImmunSpotS6)
We provide ELISpot services using the ImmunSpotS6 system, used crucial for measuring cellular immune responses at the single-cell level. This technique is widely used in immunology research and vaccine development.
This assay is widely used in vaccine trials and immune monitoring programs.
Certifications and Compliance
Our laboratory in Jining has achieved several important certifications, demonstrating our commitment to quality and compliance:
CAP accredited since 2020.
Human Genetics Resources Administration of China (HGRAC): Ensures adherence to local genetic resource regulations.
Biosafety Level 2 Certification
Import Permits: Allows timely receipt of necessary reagents and specimens for assay qualification and transfer.
These certifications ensure robust compliance and adherence to regulatory standards for clinical studies in China.
Global Reach and Expertise
CellCarta’s global network, including our Jining laboratory, ensures that high-quality sample processing services are accessible worldwide.
Our strategically located facilities and partnerships with local laboratories enable us to provide consistent and reliable services across the globe.
Our team of highly trained professionals adheres to international standards, ensuring uniformity and precision for every sample processed.
Our local experts ensure we meet all necessary regulatory standards, including supporting HGRAC applications, import and export of samples, and NMPA submissions.
As a global CRO, we provide region-specific sample logistics, globally standardized SOPs, global assay transfer, and data delivery for multi-site clinical trials.
Why Choose CellCarta?
At CellCarta, we understand the critical importance of every sample. Our dedication to maintaining high standards, combined with innovative solutions and a global reach, sets us apart as a leader in the field of sample processing.
Partner with CellCarta- a trusted CRO in China to access advanced immunology, genomics, and biomarker platforms for regional and global clinical trials.
In 2019, CellCarta proudly opened a state-of-the-art CRO laboratory in Jining, China, expanding our global footprint to support the evolving needs of clinical research.
This facility plays a key role in our global CRO network, serving biopharma clients with clinical trials running in China.
It is equipped with advanced technologies and offers a comprehensive suite of services designed to deliver high-quality data and reliable results for a variety of scientific and clinical applications.
Watch the video to discover our China laboratory:
Exclusive Services by CellCarta: A Quick Overview
Flow Cytometry Service
Our Jining laboratory is equipped with the following flow cytometry platforms: BD FACSLyric™ and BD LSRFortessa™.
As a global CRO with extensive flow cytometry expertise, we support discovery and preclinical research in addition to clinical trials across therapeutic areas.
Immunohistochemistry (IHC) and In Situ Hybridisation (ISH)
We offer robust IHC and ISH services, essential for detailed tissue analysis and molecular diagnostics.
Our techniques ensure accurate detection and localization of biomarkers, providing critical insights for various research applications, and the high quality data required for regulatory submissions.
Genomic Services
Our genomic services include real-time PCR and NanoString technologies. Real-time PCR allows for precise quantification of nucleic acids, while NanoString offers high-throughput gene expression analysis.
Proteomic and Immunoassay Services
Our Jining laboratory utilizes the Olink® and Meso Scale Discovery (MSD) platforms for high throughput proteomic analyses. These technologies facilitate comprehensive cytokine profiling and biomarker discovery, supporting translational research and global clinical studies.
ELISpot (ImmunSpotS6)
We provide ELISpot services using the ImmunSpotS6 system, used crucial for measuring cellular immune responses at the single-cell level. This technique is widely used in immunology research and vaccine development.
This assay is widely used in vaccine trials and immune monitoring programs.
Certifications and Compliance
Our laboratory in Jining has achieved several important certifications, demonstrating our commitment to quality and compliance:
CAP accredited since 2020.
Human Genetics Resources Administration of China (HGRAC): Ensures adherence to local genetic resource regulations.
Biosafety Level 2 Certification
Import Permits: Allows timely receipt of necessary reagents and specimens for assay qualification and transfer.
These certifications ensure robust compliance and adherence to regulatory standards for clinical studies in China.
Global Reach and Expertise
CellCarta’s global network, including our Jining laboratory, ensures that high-quality sample processing services are accessible worldwide.
Our strategically located facilities and partnerships with local laboratories enable us to provide consistent and reliable services across the globe.
Our team of highly trained professionals adheres to international standards, ensuring uniformity and precision for every sample processed.
Our local experts ensure we meet all necessary regulatory standards, including supporting HGRAC applications, import and export of samples, and NMPA submissions.
As a global CRO, we provide region-specific sample logistics, globally standardized SOPs, global assay transfer, and data delivery for multi-site clinical trials.
Why Choose CellCarta?
At CellCarta, we understand the critical importance of every sample. Our dedication to maintaining high standards, combined with innovative solutions and a global reach, sets us apart as a leader in the field of sample processing.
Partner with CellCarta- a trusted CRO in China to access advanced immunology, genomics, and biomarker platforms for regional and global clinical trials.
Data Analysis Simplified | Book Your Demo with CellCarta
It’s easy to analyze cytometry data with CellCarta. Discover the software our experts use to get the job done right.
Watch the CellEngine Demo:
Our team of experts harness the potential of multiparametric flow cytometry. We work with you to deliver both qualitative and quantitative analyses of samples using a wide range of high throughput and multiplexing instruments – including spectral flow!
Our flow cytometry platforms are in North America, Europe, China, and Australia, which allows us to support flow cytometry assays for global trials. All sites are equipped with the latest technology in the field.
Identify, quantify, and monitor your cell population of interest as well as its functional activity using off-the-shelf or highly customized panels. Our scientists are experts in both flow cytometry and immunology. They can guide you towards the right panels, so you get the most insight out of your samples.
CellEngine®: A New Generation of Cytometry Software
Our immunologists collaborated with our bioinformatics team to design CellEngine® – a cytometry software adapted to your needs:
Cloud-based for easy collaboration
Blasting fast analysis
Advanced visualization
Advanced API – with potential LIMS integration
Metadata-driven analysis
21 CFR 11 compliant
Learn more about the power of CellEngine and its automation tools in a recent article by our expert!
Data Analysis Simplified | Book Your Demo with CellCarta
It’s easy to analyze cytometry data with CellCarta. Discover the software our experts use to get the job done right.
Watch the CellEngine Demo:
Our team of experts harness the potential of multiparametric flow cytometry. We work with you to deliver both qualitative and quantitative analyses of samples using a wide range of high throughput and multiplexing instruments – including spectral flow!
Our flow cytometry platforms are in North America, Europe, China, and Australia, which allows us to support flow cytometry assays for global trials. All sites are equipped with the latest technology in the field.
Identify, quantify, and monitor your cell population of interest as well as its functional activity using off-the-shelf or highly customized panels. Our scientists are experts in both flow cytometry and immunology. They can guide you towards the right panels, so you get the most insight out of your samples.
CellEngine®: A New Generation of Cytometry Software
Our immunologists collaborated with our bioinformatics team to design CellEngine® – a cytometry software adapted to your needs:
Cloud-based for easy collaboration
Blasting fast analysis
Advanced visualization
Advanced API – with potential LIMS integration
Metadata-driven analysis
21 CFR 11 compliant
Learn more about the power of CellEngine and its automation tools in a recent article by our expert!
Global Sample Processing for Clinical Trials
May 1, 2024
High-Quality Sample Processing by CellCarta for Clinical Trials
In the rapidly evolving landscape of clinical research, the integrity and quality of biological samples are paramount. CellCarta’s Global Sample Processing Network is designed to support the complex needs of modern clinical trials by providing comprehensive sample processing services.
Our network ensures consistent, high-quality data through rigorous standardization and state-of-the-art technology, making us a trusted CRO partner for researchers worldwide seeking reliable clinical trial support.
CellCarta’s Comprehensive Service Overview
PBMC Processing Services
At CellCarta, we specialize in the isolation and cryopreservation of Peripheral Blood Mononuclear Cells (PBMCs). Utilizing both methodologies (Ficoll and CPT tube separation), we maintain high cell viability and recovery rates.
Our globally harmonized Standard Operating Procedures (SOPs) ensure that every sample is processed to the highest standards, irrespective of its origin. This meticulous approach minimizes variability, providing reliable processed samples for downstream applications like biomarker analysis by flow cytometry, and further immune monitoring.
Global Logistics and Sample Solutions
Our logistics network is optimized for the safe and efficient transport of clinical samples. We monitor samples and ensure integrity during transport. Our rapid turnaround time (TAT) is a critical feature, ensuring timely data for your clinical trials.
We operate as a global CRO logistics provider, with end-to-end handling and secure tracking of specimens from clinic to lab. Our real-time tracking and global footprint are key elements for global clinical programs, ensuring we maintain high quality of clinical samples.
Specialized Capabilities
Our laboratories are equipped to handle various sample types, including frozen tissue and FFPE blocks. We offer bespoke services, such as the normalization of cell numbers and the use of specialized freezing media, to meet the unique requirements of your research.
These capabilities, along with advanced logistics for multi-center trials make CellCarta the CRO logistics partner of choice for your oncology, immunology, infectious diseases, and ADC development programs.
Case Studies and Client Testimonials
Our success stories speak volumes about our capabilities. From supporting large-scale immuno-oncology trials to providing specialized PBMC processing for smaller studies, CellCarta has been at the forefront of advancing scientific research.
Clients consistently commend our reliability, expertise, and commitment to quality, making us their preferred sample analysis CRO partner.
Global Reach and Expertise
With a network spanning multiple continents, CellCarta ensures that high-quality sample processing services are accessible globally. Our strategically located laboratories and partnerships with local facilities enable us to provide consistent services worldwide.
Our team of highly trained professionals adheres to global standards, ensuring uniformity and precision in every sample processed. As a specialized CRO with global infrastructure, we’re equipped to manage complex sample pipelines across clinical sites in North America, Europe, Asia and Australia.
Quality Assurance and Compliance
Quality is at the core of our operations. We employ a comprehensive quality control program that includes regular proficiency testing and real-time monitoring of processing metrics. Our facilities comply with international standards, and we hold various certifications that underscore our commitment to excellence.
Why Choose CellCarta?
At CellCarta, we understand that every sample is crucial. Our dedication to maintaining high standards, combined with our innovative solutions and global reach, sets us apart as a leader in the field of sample processing.
Partner with CellCarta, a global CRO trusted by biopharma leaders to ensure sample quality, data integrity, and operational efficiency at every step of your clinical trial journey.
Global Sample Processing for Clinical Trials
May 1, 2024
High-Quality Sample Processing by CellCarta for Clinical Trials
In the rapidly evolving landscape of clinical research, the integrity and quality of biological samples are paramount. CellCarta’s Global Sample Processing Network is designed to support the complex needs of modern clinical trials by providing comprehensive sample processing services.
Our network ensures consistent, high-quality data through rigorous standardization and state-of-the-art technology, making us a trusted CRO partner for researchers worldwide seeking reliable clinical trial support.
CellCarta’s Comprehensive Service Overview
PBMC Processing Services
At CellCarta, we specialize in the isolation and cryopreservation of Peripheral Blood Mononuclear Cells (PBMCs). Utilizing both methodologies (Ficoll and CPT tube separation), we maintain high cell viability and recovery rates.
Our globally harmonized Standard Operating Procedures (SOPs) ensure that every sample is processed to the highest standards, irrespective of its origin. This meticulous approach minimizes variability, providing reliable processed samples for downstream applications like biomarker analysis by flow cytometry, and further immune monitoring.
Global Logistics and Sample Solutions
Our logistics network is optimized for the safe and efficient transport of clinical samples. We monitor samples and ensure integrity during transport. Our rapid turnaround time (TAT) is a critical feature, ensuring timely data for your clinical trials.
We operate as a global CRO logistics provider, with end-to-end handling and secure tracking of specimens from clinic to lab. Our real-time tracking and global footprint are key elements for global clinical programs, ensuring we maintain high quality of clinical samples.
Specialized Capabilities
Our laboratories are equipped to handle various sample types, including frozen tissue and FFPE blocks. We offer bespoke services, such as the normalization of cell numbers and the use of specialized freezing media, to meet the unique requirements of your research.
These capabilities, along with advanced logistics for multi-center trials make CellCarta the CRO logistics partner of choice for your oncology, immunology, infectious diseases, and ADC development programs.
Case Studies and Client Testimonials
Our success stories speak volumes about our capabilities. From supporting large-scale immuno-oncology trials to providing specialized PBMC processing for smaller studies, CellCarta has been at the forefront of advancing scientific research.
Clients consistently commend our reliability, expertise, and commitment to quality, making us their preferred sample analysis CRO partner.
Global Reach and Expertise
With a network spanning multiple continents, CellCarta ensures that high-quality sample processing services are accessible globally. Our strategically located laboratories and partnerships with local facilities enable us to provide consistent services worldwide.
Our team of highly trained professionals adheres to global standards, ensuring uniformity and precision in every sample processed. As a specialized CRO with global infrastructure, we’re equipped to manage complex sample pipelines across clinical sites in North America, Europe, Asia and Australia.
Quality Assurance and Compliance
Quality is at the core of our operations. We employ a comprehensive quality control program that includes regular proficiency testing and real-time monitoring of processing metrics. Our facilities comply with international standards, and we hold various certifications that underscore our commitment to excellence.
Why Choose CellCarta?
At CellCarta, we understand that every sample is crucial. Our dedication to maintaining high standards, combined with our innovative solutions and global reach, sets us apart as a leader in the field of sample processing.
Partner with CellCarta, a global CRO trusted by biopharma leaders to ensure sample quality, data integrity, and operational efficiency at every step of your clinical trial journey.
Comprehensive Histology and Pathology Services by CellCarta
November 22, 2022
Explore Our Advanced Histopathology Laboratories!
As a leading contract research organization (CRO), we offer a wide array of histopathology services.
Our histopathology facilities have trained in-house pathologists and multiple platforms to partner with you and provide integrated solutions for your specific clinical trial needs.
We deliver preclinical and clinical histology support to pharmaceutical and biotech sponsors worldwide.
Discover how CellCarta advances histopathology research and services.
We offer testing services for all phases of clinical trials including:
As a CAP/CLIA-certified CRO Lab, we support clinical studies for diagnostic and pharmaceutical partners in preparation for FDA, EU, and other global submissions.
Our digital pathology services and AI powered workflows provide scalable solutions for high-throughput histology testing across disease areas.
Histology CRO and Pathology CRO Services
Building on our comprehensive services, CellCarta’s Histology CRO capabilities extend to custom assay development and validation, supporting a wide range of clinical and research applications.
Our expert team provides histology support for CROs, offering tailored solutions to meet the specific requirements of each study. This includes detailed consultation on sample preparation, staining protocols, and data interpretation.
We offers both off-the-shelf and customized routine and advanced digital histology services, with an expert team ensuring reproducibility, scalability, and regulatory readiness.
Advanced Molecular and Digital Pathology Services
In addition to our core services, we provide advanced molecular pathology services, including in situ hybridization (ISH) and fluorescence in situ hybridization (FISH).
These techniques enable the detection of specific biomarkers and genetic materials within tissue samples, aiding in the identification and characterization of diseases.
Our digital pathology platforms, featuring whole slide imaging and automated image analysis, allows for accurate, reproducible data generation and efficient workflow management.
Collaborations and Software Solutions
We collaborate with industry leaders to enhance our service offerings and stay at the forefront of histopathology innovations.
Our histopathology software, including advanced AI-driven platforms, streamline data analysis and provide deeper insights into your samples.
This integration of cutting-edge technology ensures that our clients receive the most reliable and insightful data possible, ensuring CellCarta provides top CRO pathology services for your oncology, immunology, and biomarker programs regardless of disease area.
Quality Assurance and Global Compliance
Our commitment to quality goes beyond our technical capabilities. As a CAP/CLIA certified lab, we adhere to stringent quality control measures and global standards.
This ensures that our data and analyses are robust, reproducible, and ready for regulatory submissions worldwide, including FDA and EU approvals.
Our comprehensive quality assurance program includes regular proficiency testing and adherence to best practices in laboratory operations.
Why Choose CellCarta?
CellCarta offers unparalleled expertise in histopathology CRO services, making us a trusted partner for pharmaceutical companies and research institutions.
Whether you require IHC CRO services, digital pathology support, or full-service histopathology assay development, our team is equipped to deliver high-quality data.
Our comprehensive range of services, from routine histology to advanced molecular analyses, combined with our commitment to quality and innovation, ensures that we deliver accurate, high-quality data tailored to your specific needs.
Comprehensive Histology and Pathology Services by CellCarta
November 22, 2022
Explore Our Advanced Histopathology Laboratories!
As a leading contract research organization (CRO), we offer a wide array of histopathology services.
Our histopathology facilities have trained in-house pathologists and multiple platforms to partner with you and provide integrated solutions for your specific clinical trial needs.
We deliver preclinical and clinical histology support to pharmaceutical and biotech sponsors worldwide.
Discover how CellCarta advances histopathology research and services.
We offer testing services for all phases of clinical trials including:
As a CAP/CLIA-certified CRO Lab, we support clinical studies for diagnostic and pharmaceutical partners in preparation for FDA, EU, and other global submissions.
Our digital pathology services and AI powered workflows provide scalable solutions for high-throughput histology testing across disease areas.
Histology CRO and Pathology CRO Services
Building on our comprehensive services, CellCarta’s Histology CRO capabilities extend to custom assay development and validation, supporting a wide range of clinical and research applications.
Our expert team provides histology support for CROs, offering tailored solutions to meet the specific requirements of each study. This includes detailed consultation on sample preparation, staining protocols, and data interpretation.
We offers both off-the-shelf and customized routine and advanced digital histology services, with an expert team ensuring reproducibility, scalability, and regulatory readiness.
Advanced Molecular and Digital Pathology Services
In addition to our core services, we provide advanced molecular pathology services, including in situ hybridization (ISH) and fluorescence in situ hybridization (FISH).
These techniques enable the detection of specific biomarkers and genetic materials within tissue samples, aiding in the identification and characterization of diseases.
Our digital pathology platforms, featuring whole slide imaging and automated image analysis, allows for accurate, reproducible data generation and efficient workflow management.
Collaborations and Software Solutions
We collaborate with industry leaders to enhance our service offerings and stay at the forefront of histopathology innovations.
Our histopathology software, including advanced AI-driven platforms, streamline data analysis and provide deeper insights into your samples.
This integration of cutting-edge technology ensures that our clients receive the most reliable and insightful data possible, ensuring CellCarta provides top CRO pathology services for your oncology, immunology, and biomarker programs regardless of disease area.
Quality Assurance and Global Compliance
Our commitment to quality goes beyond our technical capabilities. As a CAP/CLIA certified lab, we adhere to stringent quality control measures and global standards.
This ensures that our data and analyses are robust, reproducible, and ready for regulatory submissions worldwide, including FDA and EU approvals.
Our comprehensive quality assurance program includes regular proficiency testing and adherence to best practices in laboratory operations.
Why Choose CellCarta?
CellCarta offers unparalleled expertise in histopathology CRO services, making us a trusted partner for pharmaceutical companies and research institutions.
Whether you require IHC CRO services, digital pathology support, or full-service histopathology assay development, our team is equipped to deliver high-quality data.
Our comprehensive range of services, from routine histology to advanced molecular analyses, combined with our commitment to quality and innovation, ensures that we deliver accurate, high-quality data tailored to your specific needs.